%0 Journal Article %A David G Tingay %A Olivia Farrell %A Jessica Thomson %A Elizabeth J Perkins %A Prue M Pereira-Fantini %A Andreas D Waldmann %A Christoph Rüegger %A Andy Adler %A Peter G Davis %A Inéz Frerichs %T Unravelling the complexities of the first breaths of life %D 2020 %R 10.1101/2020.07.29.20161166 %J medRxiv %P 2020.07.29.20161166 %X Background The transition to air-breathing at birth is a seminal, but poorly understood, respiratory event common to all humans. The objectives of this prospective, observational study were to describe the spatiotemporal gas flow, aeration and ventilation patterns occurring within the lung in neonates during successful respiratory transition.Methods Electrical impedance tomography was used to image intrathoracic volume patterns for every breath until six minutes from birth in term infants not needing resuscitation. Breaths were classified by video data, and measures of lung aeration, tidal flow conditions and intrathoracic volume distribution calculated for each inflation.Findings 1401 breaths (n=17 neonates) met eligibility and data analysis criteria. Stable functional residual capacity was obtained by median (IQR) 43 (21, 77) breaths. Breathing patterns changed from predominantly crying (80.9% first minute) to tidal breathing (65.3% sixth minute). Tidal ventilation was inhomogeneous at birth, favouring the right and non-dependent lung; p<0.001 versus left and dependent lung (mixed effects model). Initial crying created a unique pattern with delayed mid-expiratory gas flow associated with intrathoracic volume redistribution (pendelluft flow) within the lung. This preserved functional residual capacity (70.8% cries), especially within the dorsal and right lung.Interpretation The commencement of air-breathing at birth generates unique flow and volume states associated with marked spatiotemporal ventilation inhomogeneity not seen elsewhere in respiratory physiology. At birth neonates innately brake expiratory flow to defend functional residual capacity gains and redistribute gas to less aerated regions.Funding National Health and Medical Research Council (Australia).Evidence before this study Birth requires the rapid transition from a fluid-filled to aerated lung. Despite being a seminal event for all humans, very little is understood about the physiological processes supporting the transition to air-breathing. Radiological and interventional studies from more than 40 years ago suggest that respiratory success at birth requires high intrathoracic pressure and flow states. Imaging studies in animals indicate that braking expiratory flow aids generating functional residual capacity.Added value of this study In term neonates during successful respiratory transition, breath-by-breath imaging of the intrathoracic gas flow and volume patterns within the lungs was possible with electrical impedance tomography. We found that aeration and ventilation were not uniform, with highly inhomogeneous, spatiotemporal volume patterns during attainment of functional residual capacity. Crying at birth created a unique expiratory pattern that allowed intrathoracic volume redistribution (pendelluft flow) within the lung, and preserved functional residual capacity. We hypothesise that newborns defend aeration from intrathoracic lung-fluid shifts by innately braking flow using the glottis and diaphragm.Implications of all the available evidence Real-time imaging of intrathoracic volume patterns in humans is practical and may offer measures that identify neonates needing resuscitation. Whilst inspiration generated aeration, expiration is equally important to the respiratory transition. Expiratory braking is essential as a mechanism of defending aeration; suggesting that positive end-expiratory pressure is likely to be the most important method of supporting the failing human lung at birth.Competing Interest StatementAW was an employee of Swisstom AG (Landquart, Switzerland), who initially developed the EIT hardware and software systems (Swisstom was acquired by Sentec AG after the study was completed). Swisstom was not involved in study design, implementation, analysis, interpretation or reporting. IF and AW were investigators in an European Union Horizon 2020 Research and Innovation program grant to develop an infant EIT chest imaging system (CRADL project, Grant ID 668259). IF also reports funding from another European Union Horizon 2020 project (WELMO, Grant ID 825572) and reimbursement of speaking fees, congress and travel costs by Draeger Medical (a company that produces a commercial EIT unit). No author received an honorarium, grant, or other form of payment to produce the manuscript. The study was not commissioned and no commercial agencies were involved in any aspect of this study. The authors have no other competing interests to declare.Clinical TrialAustralian New Zealand Clinical Trials Registry (ACTRN12618000128291)Funding StatementThis study is supported by the Victorian Government Operational Infrastructure Support Program (Melbourne, Australia) and a grant from a National Health and Medical Research Council Centre of Research Excellence (Grant ID 1057514). DGT is supported by a National Health and Medical Research Council Clinical Career Development Fellowship (Grant ID 1053889). PGD is supported by a National Health and Medical Research Council Program Grant (Grant ID 606789). PGD is supported by a National Health and Medical Research Council Practitioner Fellowship (Grant ID 556600).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Royal Womens Hospital Human Research and Ethics Committee (#16-33).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndividual participant data collected during the study, after de-identification, and study protocols and statistical analysis code are available beginning 3 months and ending 23 years following article publication to researchers who provide a methodological sound proposal, with approval by an independent review committee (learned intermediatry) identified for purpose. Data is available for analysis to achieve aims in the approved proposal. Proposals should be directed to david.tingay@mcri.edu.au; to gain access, data requestors will need to sign a data access or material transfer agreement approved by the Murdoch Childrens Research Institute.AUArbitrary UnitsCoVCentre of VentilationEITElectrical Impedance TomographyFRCFunctional Residual CapacityPEFPeak Expiratory FlowPIFPeak Inspiratory FlowSpO2Peripheral oxygen saturationτTime constant (tau)TiInspiratory timeTeExpiratory timeVTTidal Volume %U https://www.medrxiv.org/content/medrxiv/early/2020/07/30/2020.07.29.20161166.full.pdf